112 related articles for article (PubMed ID: 25484349)
1. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
2. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms at the IL17A and IL17RA Genes are Associated with Prognosis of Papillary Thyroid Carcinoma.
Bertol BC; Góes de Araújo JN; de Carvalho KTC; Gonzaga Dos Santos M; Martelli-Palomino G; de Figueiredo Feitosa NL; Maciel LMZ; Silbiger VN; Lucena-Silva N; Freitas JCOC; Donadi EA
Arch Med Res; 2022 Feb; 53(2):163-169. PubMed ID: 34384609
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease.
Kim YG; Kim EY; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim YH
Am J Nephrol; 2012; 36(5):472-7. PubMed ID: 23147652
[TBL] [Abstract][Full Text] [Related]
5. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort.
Batalla A; Coto E; González-Lara L; González-Fernández D; Gómez J; Aranguren TF; Queiro R; Santos-Juanes J; López-Larrea C; Coto-Segura P
J Dermatol Sci; 2015 Nov; 80(2):111-5. PubMed ID: 26347322
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
7. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
8. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
9. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort.
Coto E; Gómez J; Suárez B; Tranche S; Díaz-Corte C; Ortiz A; Ruiz-Ortega M; Coto-Segura P; Batalla A; López-Larrea C
Hum Immunol; 2015 Mar; 76(2-3):75-8. PubMed ID: 25636567
[TBL] [Abstract][Full Text] [Related]
10. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
11. Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure.
Sandip C; Tan L; Huang J; Li Q; Ni L; Cianflone K; Wang DW
Medicine (Baltimore); 2016 Jul; 95(27):e4105. PubMed ID: 27399111
[TBL] [Abstract][Full Text] [Related]
12. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.
Ban JY; Kim MK; Park SW; Kwon KH
Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728
[TBL] [Abstract][Full Text] [Related]
14. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
[TBL] [Abstract][Full Text] [Related]
15. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-17A concentration and a IL17RA single nucleotide polymorphism contribute to the risk of autoimmune type 1 diabetes.
Li J; Xu L; Zhao W; Pan J; Lu J; Lu H; Yan J; Weng J; Liu F
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3547. PubMed ID: 35583128
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
Song CM; Kwon TK; Park BL; Ji YB; Tae K
Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
[TBL] [Abstract][Full Text] [Related]
19. Single Nucleotide Polymorphism of Interleukin-18 and Interleukin-18 Receptor and the Risk of Papillary Thyroid Cancer.
Chung JH; Lee YC; Eun YG; Chung JH; Kim SK; Chon S; Oh SJ; Rhee SY; Hong IK
Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):598-603. PubMed ID: 26600055
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
